Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Global Arena Holding Initiates 1 for 12 Reverse in Support of Potential Capital and Growth Endeavors
NEW YORK, NY, June 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Global Arena Holding, Inc. (the “Company”) (OTC Markets: GAHC), a growth oriented, acquisition minded company focused on specific...
-
COLUMBUS, Ohio, June 09, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
-
Guiding Researchers and Advocates to Scientific Partnerships (GRASP) launched in 2019 to unite patient advocates, physicians and researchers through meaningful discussions of cancer-related...
-
New York, June 08, 2022 (GLOBE NEWSWIRE) -- One of the essential elements predicted to drive the cutaneous fibrosis treatment market over the coming years is the rising incidence of cutaneous...
-
COLUMBUS, Ohio, May 31, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
-
Further Expands Board’s Expertise and Gender Diversity Enhances Corporate Governance BOSTON, May 20, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today...
-
Centennial Colorado, May 18, 2022 (GLOBE NEWSWIRE) -- Centennial Colorado — (May 18, 2022)- Liteye Systems, Inc. is honored to welcome Dr. Craig A Robin to their Board of Advisors. Dr. Robin’s...
-
Initiated EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Described new understanding of α4β7-expressing immune cells and MORF-057 dose response in oral presentation at ECCO...
-
COLUMBUS, Ohio, April 28, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
-
XPENG is participating in the eCar Expo in Stockholm from 29 April to 1 May, with the Flying Car XPENG X2 and intelligent EV XPENG P5 and P7 be on displayThis is the first time XPENG X2 being...